Bausch Health Americas, Inc. clinical trial pipeline

6 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 3 with minor changes only.

1. Notable

   Ranging Study to Evaluate the Safety, Efficacy, and…Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis

   Primary completion pushed from Jun 2029 to Jun 2030

   Also in this update: Completion pushed from Jan 2030 to Jan 2031

   Bausch Health Americas, Inc.·Phase 4· NCT05976802· Registry history of NCT05976802 on ClinicalTrials.gov (opens the registry)

   Updated Oct 6, 2026

2. Notable

   Bupropion Hydrobromide in Adolescents and · Major Depressive…Bupropion Hydrobromide in Adolescents and · Major Depressive Disorder

   Primary completion pushed from Jul 2029 to Jul 2030

   Also in this update: Completion pushed from Dec 2029 to Dec 2030

   Bausch Health Americas, Inc.·Phase 4· NCT02129751· Registry history of NCT02129751 on ClinicalTrials.gov (opens the registry)

   Updated Sep 29, 2026

3. Notable

   Trulance · This is a Randomized, Double-blind, Placebo-controlled…Trulance · This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC

   Enrollment reopened

   Also in this update: Trial sites expanded: 1 → 29 locations

   Bausch Health Americas, Inc.·Phase 2· NCT07723924· Registry history of NCT07723924 on ClinicalTrials.gov (opens the registry)

   Updated Oct 2, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.